Furthermore, our Western blot and IF results confirmed that knockdown of DAB2 expression significantly inhibited YAP1 activation (Fig. 6E), and the level of YAP1 activation in DAB2high GC patients was higher that in DAB2low GC patients (Fig. 6F). Here, YAP1 is linked to gastric cancer.